Infectious Diseases (except HIV/AIDS)
-
Favipiravir for Treatment of Outpatients With Asymptomatic or Uncomplicated Coronavirus Disease 2019: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
This article has 26 authors:Reviewed by ScreenIT
-
Serum SARS-CoV-2 Antigens for the Determination of COVID-19 Severity
This article has 11 authors:Reviewed by ScreenIT
-
Serological responses to COVID-19 booster vaccine in England
This article has 13 authors:Reviewed by ScreenIT
-
Protective characteristics of COVID-19 convalescent and post-vaccination IgG antibodies
This article has 14 authors:Reviewed by ScreenIT
-
HLA-A∗03:01 is associated with increased risk of fever, chills, and stronger side effects from Pfizer-BioNTech COVID-19 vaccination
This article has 10 authors:Reviewed by ScreenIT
-
Germany’s low SARS-CoV-2 seroprevalence confirms effective containment in 2020: Results of the nationwide RKI-SOEP study
This article has 19 authors:Reviewed by ScreenIT
-
Investigating SARS-CoV-2 breakthrough infections per variant and vaccine type
This article has 8 authors:Reviewed by ScreenIT
-
Effectiveness of Vaccination against Reported SARS-CoV-2 Infection in United States Coast Guard Personnel between May and August 2021: A Time-Series Analysis
This article has 8 authors:Reviewed by ScreenIT
-
The role of multi-generational household clusters in COVID-19 in England
This article has 7 authors:Reviewed by ScreenIT
-
Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales
This article has 30 authors:Reviewed by ScreenIT